Edesa Biotech, Inc.

Code

A

Shares

27,602

Price

$0.00

Footnotes

3

Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These restricted stock awards ("RSUs") represent awards received in lieu of 90% of Reporting Person's monthly base salary otherwise payable in cash, reflecting the increase in Reporting Person's annual base salary from $357,696 to $657,423, retroactive for the period from July 1, 2026 through October 10, 2026. The number of RSUs was determined by dividing such portion of the base salary by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through October 27, 2026. Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.